Piperine, a Major Constituent of Black Pepper, Inhibits Human P-glycoprotein and CYP3A4

@article{Bhardwaj2002PiperineAM,
  title={Piperine, a Major Constituent of Black Pepper, Inhibits Human P-glycoprotein and CYP3A4},
  author={R. Bhardwaj and H. Glaeser and L. Becquemont and U. Klotz and S. Gupta and M. Fromm},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2002},
  volume={302},
  pages={645 - 650}
}
Dietary constituents (e.g., in grapefruit juice; NaCl) and phytochemicals (e.g., St. John's wort) are important agents modifying drug metabolism and transport and thereby contribute to interindividual variability in drug disposition. Most of these drug-food interactions are due to induction or inhibition of P-glycoprotein and/or CYP3A4. Preliminary data indicate that piperine, a major component of black pepper, inhibits drug-metabolizing enzymes in rodents and increases plasma concentrations of… Expand
Effects of Phytochemical P-Glycoprotein Modulators on the Pharmacokinetics and Tissue Distribution of Doxorubicin in Mice
TLDR
Testing the hypothesis that phytochemical P-gp inhibitors, i.e., piperine, capsaicin and [6]-gingerol, modulate the in vivo tissue distribution of doxorubicin, a representative P- gp substrate, demonstrated their potential to induce food-drug interactions and act as a strategy for the delivery of P-GP substrate drugs to target tissues and tumors. Expand
Effects of Spice Constituents on P-Glycoprotein-Mediated Transport and CYP3A4-Mediated Metabolism in Vitro
TLDR
Among the spices that showed inhibitory effect on midazolam (MDZ) 1′-hydroxylation and 4-hydroxy-MDZ activity were determined in pooled human liver microsomes (HLM), only AMD showed a preincubation time-dependent inhibitoryEffect on MDZ metabolism in HLM, suggesting the AMD as an irreversible CYP3A4 inhibitor. Expand
Herbal Modulation of P‐Glycoprotein
TLDR
The inhibition of PGP by herbal constituents may provide a novel approach for reversing multidrug resistance in tumor cells, whereas the stimulation of Pgp expression or activity has implication for chemoprotective enhancement by herbal medicines. Expand
Pharmacokinetic Interactions of Herbs with Cytochrome P450 and P-Glycoprotein
TLDR
Ten popular medicinal and/or dietary herbs are reviewed as perpetrators of CYP- and P-gp-mediated pharmacokinetic herb-drug interactions to provide robust fundamentals for optimizing CYP and/ or P- gp substrate drug-based therapy. Expand
Characterization of stable and reactive metabolites of piperine formed on incubation with human liver microsomes.
TLDR
The present study was designed to detect and characterize stable and RM(s) of piperine formed on in vitro incubation with human liver microsomes, and found four stable metabolites and their isomers were detected and six novel RMs'conjugates were observed. Expand
Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells.
TLDR
The present study provides further evidence that repeated exposure to dietary ingredients can cause drug-food interactions by affecting the function and mRNA expression of intestinal transporters such as P-glycoprotein. Expand
Flavonoid-Mediated Modulation of CYP3A Enzyme and P-Glycoprotein Transporter: Potential Effects on Bioavailability and Disposition of Tyrosine Kinase Inhibitors
The consumption of herbal products and dietary supplements along with conventional medicines has raised concerns regarding herb-drug interactions. The available literature from experimental andExpand
Co-Use of Drugs and Herbal Remedies in General Practice and In Vitro Inhibition of CYP3A4, CYP2D6 and P-Glycoprotein by the Common Herb Aloe Vera.
TLDR
Aloe vera juice (AVJ) inhibits the bidirectional transport of the P-gp substrate digoxin (30 nm) in vitro if AVJ is present in clinically relevant concentrations, butAVJ is no inhibitor of theP-gp mediated transport of digoxin in vitro, indicating that AVJ has no role in P-glycoprotein inhibition studies. Expand
In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression.
TLDR
The data suggest that caution should be exercised when piperine is to be co-administered with drugs that are P-gp substrates, particularly for patients whose diet relies heavily on pepper. Expand
Curcumin, Piperine, and Capsaicin: A Comparative Study of Spice-Mediated Inhibition of Human Cytochrome P450 Isozyme Activities
TLDR
Of the three SCs, CAP has the strongest potential for further development into an inhibitor of multiple CYPs for use in the clinic and is useful for managing potential drug–SC interactions. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 45 REFERENCES
Drug-grapefruit juice interactions.
TLDR
This review discusses the proposed mechanisms of action and the medications involved in drug-grapefruit juice interactions and addresses the clinical implications of these interactions. Expand
Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.
TLDR
It is concluded that verapamil phase I metabolites exhibit different P-glycoprotein substrate and inhibition characteristics, with the N-dealkylated metabolites D-617 and D-620 being P- Glycoprotein substrates and norverapamIL and D -703 being inhibitors of P- glycoprotein function, which may influence P- glucosecoprotein-dependent drug disposition and elimination. Expand
Differences in the effects of piperine and piperonyl butoxide on hepatic drug-metabolizing enzyme system in rats.
TLDR
The results point up that the effect of p Piperine on hepatic mixed-function oxidases is monophasic while that of piperonyl butoxide is biphasic. Expand
The barrier function of CYP3A4 and P-glycoprotein in the small bowel.
  • Watkins
  • Biology, Medicine
  • Advanced drug delivery reviews
  • 1997
TLDR
Characterization of the roles of CYP3A4 and Pgp in limiting oral drug availability may be aided by recent success in the development of human intestinal cell lines that stably express both CYP-glycoprotein and PGP. Expand
The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans.
  • Wilkinson
  • Biology, Medicine
  • Advanced drug delivery reviews
  • 1997
TLDR
The extent of this effect appears to be unpredictable, both with respect to a specific drug as well as a particular individual, and the greatest age-related change in oral bioavailability and plasma concentrations is likely to occur with drugs that exhibit a significant first-pass effect in young subjects. Expand
Influence of dietary components on the gastrointestinal metabolism and transport of drugs.
  • A. Evans
  • Chemistry, Medicine
  • Therapeutic drug monitoring
  • 2000
TLDR
There is widespread recognition that the ingestion of a meal is associated with a number of physiologic changes that can significantly alter the rate and extent of drug absorption, and it is reasonable to suspect that isoflavones may alter drug disposition in humans. Expand
Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin
TLDR
Data indicate that prehepatic metabolism of verapamil (presumably in the gut wall) is preferentially induced compared with hepatic metabolism and that stereoselectivity of verAPamil metabolism is affected by induction. Expand
Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments].
TLDR
The in vivo data strongly support the hypothesis that inhibition of P-glycoprotein-mediated digoxin elimination plays an important role in the increase of plasma digoxin concentration occurring with quinidine coadministration in wild-type mice and thus support a similar mechanism in humans. Expand
P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans.
TLDR
It is concluded that Pgp-mediated transport is a critical element influencing the CYP3A inductive response. Expand
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin.
TLDR
Concomitant administration of rifampin reduced digoxin plasma concentrations substantially after oral administration but to a lesser extent after intravenous administration, and induction of intestinal P-gp could explain this new type of drug-drug interaction. Expand
...
1
2
3
4
5
...